The Ministry of Health of Ukraine has registered the drug "Molnupiravir" for emergency use. Ego is used to treat COVID-19, first of all, in risk groups, to protect patients from the transition from mild to moderate to severe. About this reported press service of the Ministry of Health.
"We started to prepare for the next wave of Covid-300 ahead of time. Therefore, even last year, negotiations began on the purchase of XNUMX courses of the drug "Molnupiravir," noted First Deputy Minister of Health Alexander Komarida.
According to him, the Ministry of Health has now completed the registration of the drug, so its deliveries are expected in the near future.
Note, "Molnupiravir" is a direct-acting drug in the form of tablets that blocks the enzyme necessary for the virus to reproduce its genetic code. Thus, it prevents the reproduction of the virus and reduces the risk of a severe course of the disease.
In the world, this medicine is used for patients who have at least one risk factor: overweight, age over 60 years, diabetes or heart disease.
Let us remind you that at the end of November, the American company producing Molnupiravir tablets for the treatment of COVID-19 stated that they are significantly less effective than previously stated. They showed a 30% reduction in hospitalizations and deaths from COVID-19, although the company previously talked about a 50% reduction.
